Walvax Biotechnology Co (SZSE:300142) Debt-to-Asset : 0.05 (As of Mar. 2024)

Walvax Biotechnology Co Debt-to-Asset Chart

Walvax Biotechnology Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Asset		Get a 7-Day Free Trial					-	0.01	0.02	0.03	0.05

Walvax Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.03	0.04	0.04	0.05	0.05

Competitive Comparison of Walvax Biotechnology Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Walvax Biotechnology Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's Debt-to-Asset falls into.

Walvax Biotechnology Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Walvax Biotechnology Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Walvax Biotechnology Co's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walvax Biotechnology Co  (SZSE:300142) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Walvax Biotechnology Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Walvax Biotechnology Co (SZSE:300142) Business Description